Hims & Hers Health, Inc. reported $2.58B of revenue over the trailing twelve months, +28% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.58B (to Q2 2026). Net Income: −$142M, trailing twelve months to Q2 2026. Free Cash Flow: $62M, trailing twelve months to Q2 2026. Op Margin: −5.6%, trailing twelve months to Q2 2026.

HIMSHims & Hers Health, Inc.

HealthcareUSD

$29.84

$14.5252 weeks$62.76

HIMS as reported

Hims & Hers Health, Inc. reported $2.58B of revenue over the trailing twelve months, +28% on the year before. 10 reported series are charted on this page, each one as filed.

$2.58B

Revenue, trailing twelve months · to Q2 2026 · +28% against the twelve months before

Net Income: −$142M
Net Income · −173% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $62M
Free Cash Flow · −48% year on year · trailing twelve months to Q2 2026
Op Margin: −5.6%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for HIMS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.58B	+28%	Q2 2026
Net Income	−$142M	−173%	Q2 2026
EPS	−$0.63	−180%	Q2 2026
Gross Margin	69%	n/a	Q2 2026
Op Margin	−5.6%	n/a	Q2 2026
Net Margin	−5.2%	n/a	Q2 2026
ROE	−0.01%	n/a	Q2 2026
ROA	1.9%	n/a	Q2 2026
Free Cash Flow	$62M	−48%	Q2 2026
P/E	69.3	n/a	Q4 2025